Inventor · disambiguated record
Inderjit Kumar Dev
Also filed as: DEV INDERJIT K · DEV INDERJIT KUMAR
3 granted patents·9 pending applications·5 citations·filing 2001–2019
57Inventor score
Top patents by PatentIndex Score
12 records- 0173US7323476B2Myriceric acid derivatives for the treatment of cancer, cardiovascular and inflammatory diseasesSAVIPU PHARMACEUTICALS·Filed 2007·Granted Jan 29, 2008·2 cites·2 claims
- 0268US7795306B2Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of NF-κBDEV INDERJIT KUMAR·Filed 2007·Granted Sep 14, 2010·3 cites·3 claims
- 0350US2009022821A1Compositions from wax myrtle for the treatment of cancer, cardiovascular and inflammatory diseasesDEV INDERJIT KUMAR·Filed 2008·Application pending·0 cites
- 0446US2007243273A1Reduction of the Deleterious Effects of Tobacco SmokingSAVIPU PHARMACEUTICALS·Filed 2007·Application pending·0 cites
- 0546US2007161665A1Cancer treatment methodDEV INDERJIT K·Filed 2004·Application pending·0 cites
- 0641US2003171306A1Cancer treatment methodFiled 2001·Application pending·0 cites
- 0740US2008017207A1Reduction of the Deleterious Effects of Tobacco Smoking by the Induction of Phase 2 Enzymes by Nerf2SAVIPU PHARMACEUTICALS·Filed 2007·Application pending·0 cites
- 0839US2007207989A1Diterpene derivatives for the treatment of cardiovascular, cancer and inflammatory diseasesSAVIPU PHARMACEUTICALS·Filed 2007·Application pending·0 cites
- 0938US2008187608A1Enriched fractions from clary sage for the treatment of cancer, cardiovascular and inflammatory diseasesSAVIPU PHARMACEUTICALS·Filed 2008·Application pending·0 cites
- 1035US12053447B2Oral solution and powder to liquid compositions of balsalazideNUBIOPHARMA LLC·Filed 2019·Granted Aug 6, 2024·0 cites·1 claims
- 1121US2017348419A1Oral liquid suspensionsNUBIOPHARMA LLC·Filed 2016·Application pending·0 cites
- 1220US2015297534A1Methods and compositions for the mediation of nsaid-induced reactionsNUBIOPHARMA LLC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →